cardiovascular pathology Flashcards

atherosclerosis: explain the pathology, pathophysiology, and clinical features of atherosclerosis

1
Q

define atherosclerosis

A

outcome of a permanently activated endothelium, causing formation of plaques within walls of large arteries, potentially causing thrombosis or occlusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

modifiable risk factors of atherosclerosis

A

smoking, lipid intake, blood pressure, diabetes, obesity, sedentary lifestyle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

non-modifiable risk factors of atherosclerosis

A

age, sex, genetic background

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

agents which activate endothelium in atherogenesis

A

smoking, viruses, toxins, mechanical stress (turbulent flow), inflammation, hypertension, OxLDL (carried to arteries), high glucose (diabetes), ageing, oxidative stress, hypercholesterolaemia, sex hormonal imbalance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

epidemiology of atherosclerosis

A

statins and antihypertensives mean obesity is driving factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

LDL structure

A

lipid monolayer and docking apolipoproteins, with cargo fat (triglycerides and cholesterol esters)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

location of atherosclerosis

A

branch points of arteries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

why does atherosclerosis occur at branch points

A

turbulent, not laminar, flow is present, so speed changes magnitude and direction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

why does laminar flow not normally cause atherosclerosis (3)

A

activates KLF2/4 transcription factors to upregulate eNOS and anti-thrombotic and anti-inflammatory factors; also promotes nitric oxide production and inhibition of smooth muscle cell proliferation; downregulates DNA methyltransferases to allow continued demethylation of anti-atherotic gene promoter regions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

why can turbulent flow cause atherosclerosis (6)

A

activates NK-kappaB for pro-inflammatory effects; upregulates DNMT to hypermethalate which repress anti-therotic genes; promotes coagulation, leukocyte adhesion, smooth muscle cell proliferation, endothelial apoptosis and reduced nitric oxide production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the 6 protective effects of nitric oxide on vascular endothelium

A

dilates blood vessels, reduces platelet activation, inhibits monocyte adhesion, reduces proliferation of smooth muscle cells in vessel wall, reduces release of superoxide radicals, reduces oxidation of LDL cholesterol (plaque)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how does blood flow regulate gene expression

A

transcription factors selectively activated by laminar (e.g. eNOS for NO production) or turbulent (e.g. NF-KB) flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

blood flow regulation of endothelial epigenetic pathways

A

mechanosensors sense blood flow and cause changes in transcription by regulating chromatin (epigenetic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

3 stages of pathogenesis of atherosclerosis

A

endothelial dysfunction, fatty streak formation, advanced complicated lesion formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

summary of endothelial dysfunction

A

endothelium in large vessels receive chronic stimuli of inflammation increase, increasing permeability and causing leukocyte accumulation under activated endothelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

summary of fatty streak formation

A

lipids get stuck under more permeable endothelium, binding to proteoglycans and becoming oxidised, before engulfment by macrophages, forming foam cells (fatty streaks)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

summary of advanced complicated lesion formation

A

other chronic processes such as macrophage accumulation, necrosis, senescence and angiogenesis cause an advanced complicated lesion to form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what blood vessels does leukocyte recruitment occur in normaly vs in atherosclerosis

A

normally affects post-capillary venules by contact inhibition, but in atherosclerosis it affects large arteries, as all stimuli activate endothelium in wrong place

19
Q

define contact inhibition and how does this contribute to formation of endothelial junctions

A

when cells in monolayer touch they stop proliferating and enter senescence; when leukocytes need to enter tissue they squeeze through these junctions in capillaries, but this is not possible in thick arteries due to layers of smooth muscle

20
Q

what is the effect of increased endothelial permeability in major arteries

A

leakage of plasma proteins (including lipoproteins) through junctions into subendothelial space, as well as oedema

21
Q

leukocyte recruitment in atherosclerosis: effect on monocytes

A

monocytes stuck between endothelium and smooth wall mature into macrophages

22
Q

leukocyte recruitment in atherosclerosis: how do leukocytes pass through endothelium when there is an inflammatory trigger (captured by intra-vital microscopy)

A

leukocytes roll, but when inflammatory trigger become activated; adhesion molecules on surface bind to leukocytes and adhesion strengthens; leukocyte flattens and spreads out, then migrates through tight junctions in endothelium (para or transcellular)

23
Q

outcome and fate of lipoproteins entering endothelium

A

lipoprotein pass through endothelium and are oxidised; macrophages present in subendothelial space then consume the lipoproteins and become foam cells, forming a fatty streak

24
Q

subtypes of macrophage scavenger receptors

A

A and B

25
Q

macrophage scavenger receptor subtype A

A

CD204, bind oxLDL, dead cells and gram +ve bacteria to cause inflammation and destruction

26
Q

macrophage scavenger receptor subtype B

A

CD36, bind oxLDL, malaria parasites and dead cells for safe clearance and reverse cholesterol transport

27
Q

5 macrophage actions

A

generate free radicals to oxidise LDL, phagocytose modified lipoproteins, express cytokine mediators to recruit monocytes, express chemo-attractants and growth factors, express metalloproteinases

28
Q

macrophages that express cytokine mediators to recruit monocytes

A

chemokines attract monocytes, cytokines activate endothelial cell adhesion molecules

29
Q

macrophages that express chemo-attractants and growth factors

A

platelet-derived growth factor and transforming growth factor B for wound healing release complementary protein growth factors to recruit muscle cells and stimulate proliferation

30
Q

fate of macrophages and effect of metalloproteinases

A

die and release pools of fat, forming necrotic core which causes fibrous thickening - if insufficient, family of enzymes that activate each other by proteolysis to degrade collagen (need zinc), degrading wall of plaque

31
Q

outcome of ruptured plaque

A

fibrous cap becomes so thin that will break and rupture, allowing necrotic core to contact blood and cause thrombus formation

32
Q

characteristics of a vulnerable cap

A

large, soft, eccentric lipid-rich necrotic core with increased smooth muscle cell apoptosis, reduced muscle/collagen content, thin fibrous cap, infiltrate of activate macrophages expressing metalloproteinases

33
Q

define angiogenesis

A

formation of new vessels by sprouting from existing vessels

34
Q

what 3 physiological functions is angiogenesis essential for

A

embyronic development, menstrual cycle, wound healing

35
Q

what is the most powerful trigger for angiogenesis

A

hypoxia (e.g. caused by atheroclerosis)

36
Q

how does angiogenesis contribute to atherosclerosis

A

promotes plaque growth

37
Q

how does angiogenesis aid in atherosclerosis

A

prevents damage post-ischaemia

38
Q

define cellular senescence and contribution to atherosclerosis

A

growth arrest that halts proliferation of ageing and/or damaged cells (e.g. protective defence against cancer); pro-inflammatory and so contribute to atherosclerosis

39
Q

two main methods of protecting endothelium and preventing atherosclerosis

A

promote anti-pathways or prevent pro-pathways (e.g. anti-inflammatory)

40
Q

what type of toxin is resveratol and what does this mean

A

hormetic toxin (in lower doses it has a protective effects on cardiovascular diseases, but at high doses it has cytotoxic effects)

41
Q

what factors can influence atheroprotective genes

A

novel therapies, statins, diet, exercise, haemodynamics, hormonal balance, epigenetics, miRNAs

42
Q

outcome of expression of atheroprotective genes

A

production of a vasoprotective endothelial phenotype which contributes to vascular homeostasis

43
Q

atherosclerosis window of opportunity

A

lifestyle changes and risk factor management during intermediate/advanced lesion stage

44
Q

clinical interventions of atherosclerosis

A

catheter based interventions, revascularisation surgery and treatment of heart failure/attacks